Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bfd9c2c1decf731d6409d54652793e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 |
filingDate |
2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe9de16c42d5e04b91a7c0955ac6e3e |
publicationDate |
2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2013109219-A1 |
titleOfInvention |
Dry powder formulations comprising tiotropium and carmoterol |
abstract |
The present invention relates to pharmaceutical formulations in dry powder form comprising tiotropium and carmoterol in order to be used in respiratory tract diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017068119-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3159277-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017033032-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017068108-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3159278-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108137205-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-034467-B1 |
priorityDate |
2012-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |